Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KOD
KOD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KOD News
KODIAK SCIENCES STOCK JUMPS 40% IN PREMARKET TRADING FOLLOWING SUCCESSFUL LATE-STAGE EYE DRUG TRIAL
4d ago
moomoo
Kodiak Sciences Reports Positive GLOW2 Results for Zenkuda in Diabetic Retinopathy
4d ago
PRnewswire
KODIAK SCIENCES INC: ZENKUDA SHOWS 85% RISK REDUCTION IN KEY SECONDARY ENDPOINT COMPARED TO PLACEBO
4d ago
moomoo
Zenkuda Shows Superiority in Diabetic Retinopathy Treatment
4d ago
Newsfilter
Kodiak Sciences Stock Surpasses Analyst Target Price
3d ago
NASDAQ.COM
KODIAK SCIENCES INC: JEFFERIES INCREASES TARGET PRICE FROM $39 TO $56
3d ago
moomoo
US Stocks Plunge Amid Soaring Oil Prices
4d ago
NASDAQ.COM
Surge in Options Volume for Kodiak and Chemours
4d ago
NASDAQ.COM
Health Care Stocks Decline Late Thursday
4d ago
Yahoo Finance
US Stocks Under Pressure Amid Soaring Oil Prices
4d ago
NASDAQ.COM
Surging Oil Prices Trigger Market Volatility
4d ago
NASDAQ.COM
Kodiak Sciences' Zenkuda Therapy Achieves Key Milestones in Phase 3 Trial
4d ago
seekingalpha
Kodiak Sciences Shares Surge 40% on Positive Phase 3 Results for Eye Drug Zenkuda
4d ago
stocktwits
Kodiak Sciences Reports Positive Phase 3 Results for Zenkuda in Diabetic Retinopathy
4d ago
NASDAQ.COM
Boxer Capital Increases Stake in Kodiak Sciences
Mar 09 2026
Fool
Baker Bros. Advisors Increases Stake in Kodiak Sciences
Feb 23 2026
Fool
Show More News
